Cargando…

Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease

BACKGROUND: Aspirin is a cornerstone in management of coronary artery disease (CAD). However, considerable variability in the antiplatelet effect of aspirin has been reported. AIM: To investigate independent determinants of reduced antiplatelet effect of aspirin in stable CAD patients. METHODS: We p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsen, Sanne Bøjet, Grove, Erik Lerkevang, Neergaard-Petersen, Søs, Würtz, Morten, Hvas, Anne-Mette, Kristensen, Steen Dalby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436265/ https://www.ncbi.nlm.nih.gov/pubmed/25993271 http://dx.doi.org/10.1371/journal.pone.0126767

Ejemplares similares

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2017)

The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin
por: Neergaard-Petersen, Søs, et al.
Publicado: (2015)

Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
por: Neergaard-Petersen, Søs, et al.
Publicado: (2013)

Coronary artery disease-associated genetic variants and biomarkers of inflammation
por: Christiansen, Morten Krogh, et al.
Publicado: (2017)

Platelet Turnover in Stable Coronary Artery Disease – Influence of Thrombopoietin and Low-Grade Inflammation
por: Larsen, Sanne Bøjet, et al.
Publicado: (2014)

Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease
por: Larsen, Sanne Bøjet, et al.
Publicado: (2015)

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

Genetic Determinants of On-Aspirin Platelet Reactivity: Focus on the Influence of PEAR1
por: Würtz, Morten, et al.
Publicado: (2014)

Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover
por: Pedersen, Oliver Heidmann, et al.
Publicado: (2017)

Feasibility and impact of whole-body high-intensity interval training in patients with stable coronary artery disease: a randomised controlled trial
por: Kristiansen, Jacobina, et al.
Publicado: (2022)

Haemostasis and fibrinolysis after regular high-intensity interval training in patients with coronary artery disease: a randomised controlled trial
por: Kristiansen, Jacobina, et al.
Publicado: (2022)

Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction
por: Maag, Emil, et al.
Publicado: (2021)

Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2022)

Advanced Flow Cytometry Using the SYTO-13 Dye for the Assessment of Platelet Reactivity and Maturity in Whole Blood
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2023)

Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study
por: Thim, Troels, et al.
Publicado: (2023)

A 19-Year-Old Man with a History of Recreational Inhalation of Nitrous Oxide with Severe Peripheral Neuropathy and Central Pulmonary Embolism
por: Pedersen, Oliver Buchhave, et al.
Publicado: (2021)

The angiotensin-converting enzyme I/D polymorphism does not impact training-induced adaptations in exercise capacity in patients with stable coronary artery disease
por: Sjúrðarson, Tórur, et al.
Publicado: (2023)

Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases
por: Kelddal, Sarah, et al.
Publicado: (2022)

Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy
por: Egholm, Gro, et al.
Publicado: (2016)

Computed tomography derived fractional flow reserve testing in stable patients with typical angina pectoris: influence on downstream rate of invasive coronary angiography
por: Jensen, Jesper Møller, et al.
Publicado: (2018)

Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study
por: Kraglund, Kristian Lundsgaard, et al.
Publicado: (2019)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark
por: Thrane, Pernille Gro, et al.
Publicado: (2022)

Cardiac Arrest Caused by Multiple Recurrent Pulmonary Embolism
por: Hannig, Kjartan Eskjaer, et al.
Publicado: (2011)

Minimally invasive treatment of left main coronary artery thrombosis in a young patient with COVID-19
por: Johnsen, Jacob, et al.
Publicado: (2022)

Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease
por: Tam, Chor-Cheung, et al.
Publicado: (2022)

Coronary Atherosclerosis and Aortic Valve Disease as Long-Term Sequelae of Radiation Therapy in Childhood
por: van den Handel Vestergaard, Majken, et al.
Publicado: (2021)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
por: Rafiq, Sulman, et al.
Publicado: (2012)

Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary Thrombophilia
por: Hellfritzsch, Maja, et al.
Publicado: (2015)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease
por: Zou, Xiao, et al.
Publicado: (2023)

Efficacy and Safety of Oral Anticoagulants in Patients with Systolic Heart Failure in Sinus Rhythm: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Cohort Studies
por: Nygaard, Marie H., et al.
Publicado: (2020)

Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials
por: Debasu, Zenaw, et al.
Publicado: (2022)

Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4lohat6ht4utbulugo54tq39o0